Awarded contractOpenSuppliesPoland

Koncentrat czynnika krzepnięcia VIII (osoczopochodnego lub rekombinowanego); znak postępowania: ZZP.ZP.411.22.2024 części: 1÷3

2 suppliers awarded•3 lots awarded•€13.44M awarded

Buyer: Narodowe Centrum Krwi / Warszawa, Poland

Published Aug 06, 2024Awarded Mar 07, 2024

Medicinal products for the blood and blood-forming organs

Awarded value

€13.44M

Estimated value

€13.44M

Awarded at 100% of estimated value

Award date

Mar 07, 2024

Winners

Lots awarded

Winners

Warszawa, POL

2 lots

€10.5M This contract

61 award notices•76 awarded lots•€50.16M total

Lachen, CHE

1 lot

€3.0M This contract

2 award notices•3 awarded lots•€4.09M total

Lot	Winner	Award value	Main CPV
LOT-0002	Takeda Pharma Sp. z o.o.	€5.4M	Medicinal products for the blood and blood-forming organs (33621000), Medicinal products for the blood and blood-forming organs (33621000)
LOT-0003	Takeda Pharma Sp. z o.o.	€5.1M	Medicinal products for the blood and blood-forming organs (33621000), Medicinal products for the blood and blood-forming organs (33621000)
LOT-0001	Octapharma AG	€3.0M	Medicinal products for the blood and blood-forming organs (33621000), Medicinal products for the blood and blood-forming organs (33621000)